List of Regeneron Pharmaceuticals's Acquisitions
Here's the year on year acquisition history of Regeneron Pharmaceuticals:
Year | # Acquisitions |
|---|---|
2025 | 1 |
2023 | 1 |
2022 | 1 |
Recent acquisitions by Regeneron Pharmaceuticals
Regeneron Pharmaceuticals's most recent acquisition - Oxular is a Developer of drug delivery platform and therapeutics for ophthalmology, founded in 2014 and located in Oxford. Regeneron Pharmaceuticals acquired it in January 2025 for a price of $*****.
Here is the list of all acquisitions by Regeneron Pharmaceuticals sorted by the latest acquisition date:
Acquired on | Acquired Company | Acquisition Price | Facilitators | Stake Acquired | Acquisition Multiple |
|---|---|---|---|---|---|
Jan 02, 2025 | fk{s | gawe | 58 | 345 | |
Aug 10, 2023 | ytnr | nhjh | 24 | 381 | |
Apr 19, 2022 | alsa | pf{p | 46 | 722 |
News related to Regeneron Pharmaceuticals's acquisitions
Media has covered Regeneron Pharmaceuticals for a total of 150 events in the last 1 year, 13 of them have been about acquisition activity.
•
Regeneron and CytomX Extend Cancer Therapy Partnership to $4bn DealHospital Management•Jun 04, 2026•CytomX Therapeutics, Regeneron Pharmaceuticals
•
•
•
A $2.1 Billion Radiopharmaceutical Collaboration, ExplainedPharmtech•Apr 14, 2026•Telix Pharma, Regeneron Pharmaceuticals
•
Dupixent® Approved in EU for Young Children with Chronic Spontaneous UrticariaGlobeNewswire•Apr 13, 2026•Regeneron Pharmaceuticals, Sanofi, Telix Pharma
•
•
OPKO Health Reports Fourth Quarter 2025 Business HighlightsGlobeNewswire•Feb 27, 2026•Opko Health, Regeneron Pharmaceuticals
•
•
Tessera inks $150M partnership deal with RegeneronEndpoints•Dec 01, 2025•Tessera Therapeutics, Regeneron Pharmaceuticals
•
